MindMed’s recent financing has closed after being upsized all the way to CAD$34.5 million.

Aphria Inc. Announces Move to Nasdaq 2020-05-26 Melissa Schiller Aphria Inc., a global cannabis company, has announced that it will transfer its stock exchange listing from the New York Stock Exchange (NYSE) to The Nasdaq Global Select Market (Nasdaq).

Mind Cure’s initial R&D focus will be on psilocybin, ketamine and ibogaine. Researching both pain and mental health applications for psychedelics.

Champignon Brands names an interim CFO after Stephen Brohman resigns.

Leading psychedelic stocks have gone ballistic in recent weeks. But where will investors find the NEXT multi-bagger opportunity?

The company is set to open a therapeutic health and training center in Kelowna, British Columbia in May of 2021

Psychedelic stocks are hitting new highs — and doing so on record trading volumes. Feeding frenzies.

Warning: This is probably not for you.

Nebraska State Sen. Anna Wishart (D) said in a Facebook post that she is working on “ballot language for full adult use legalization,” with plans to introduce it next month.

New Jersey Gov. Phil Murphy (D) said on Friday that lawmakers have come to an agreement on the bills to legalize cannabis required by the voter-approved ballot question.